Skip to main content

Featured Article: Thrombosis-related characteristics of pregnant women with antithrombin deficiency, protein C deficiency and protein S deficiency in Japan

Antithrombin (AT) deficiency, protein C (PC) deficiency and protePicture of pregnant woman touching her stomachin S (PS) deficiency are the major types of hereditary thrombophilia in Japan. In this study, the authors examine detailed information such as the time of thrombophilia diagnosis, family history or past history of thrombophilia, onset of thrombosis during pregnancy or after delivery, thromboprophylaxis, pregnancy complications or bleeding risk from anticoagulation, and fetal/neonatal complications in pregnant women with AT deficiency, PC deficiency and PS deficiency. They also evaluate their peripartum outcomes compared to control data on pregnant women in Japan.

Read more


  1. Authors: Meyer Michel Samama, Geneviève Contant, Theodore E Spiro, Elisabeth Perzborn, Lena Le Flem, Céline Guinet, Yves Gourmelin, Gabriele Rohde and Jean-Luc Martinoli

Recommended reading

Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis

Kochawan Boonyawat, Pichika Chantrathammachart, Pawin Numthavaj, Nithita Nanthatanti, Sithakom Phusanti, Angsana Phuphuakrat, Pimjai Niparuck & Pantep Angchaisuksiri 

Thrombosis and bleeding outcomes in the treatment of cerebral venous thrombosis in cancer

Nadia I Abelhad, Wei Qiao, Naveen Garg & 

Cristhiam M. Rojas-Hernandez 

Serial markers of coagulation and inflammation and the occurrence of clinical pulmonary thromboembolism in mechanically ventilated patients with SARS-CoV-2 infection; the prospective Maastricht intensive care COVID cohort

Mark M. G. Mulder, LIoyd Brandts, Renée A. G. Brüggemann, Marcel Koelmann, Alexander S. Streng, Renske H. Olie, Hester A. Gietema, Henri M. H. Spronk, Iwan C. C. van der Horst, Jan-Willem E. M. Sels, Joachim E. Wildberger, Sander M. J. van Kuijk, Ronny M. Schnabel, Hugo ten Cate, Yvonne M. C. Henskens & Bas C. T. van Bussel 

Thiol-based Redox Regulation of Thrombosis

Edited by:
Yi Wu, MD, PhD, Soochow University, China

Submission Status: Open until 16 December 2024

The platelet derived non-coding RNAs and thrombosis: from bench to bed


Tong Yin: General Hospital of Chinese PLA, China

Submission Status: Open until 15 May 2024

Trending articles

Click here to view the most shared articles in the last month!

Aims and scope

Thrombosis Journal  is an open-access journal that publishes original articles on aspects of clinical and basic research, new methodology, case reports and reviews in the areas of thrombosis.

Topics of particular interest include the diagnosis of arterial and venous thrombosis, new antithrombotic treatments, new developments in the understanding, diagnosis and treatments of atherosclerotic vessel disease, relations between haemostasis and vascular disease, hypertension, diabetes, immunology and obesity.

Latest Tweets

Your browser needs to have JavaScript enabled to view this timeline

Asian-Pacific Society on Thrombosis and Hemostasis

The Asian-Pacific Society of Thrombosis and Hemostasis (APSTH) is a non-profit organization that welcomes any medical or scientific professionals with an interest in the field of thrombosis and hemostasis, particularly those professionals from the Asia Pacific Region.

The main objectives of APSTH are to foster and advance clinical and scientific knowledge in the field of thrombosis, hemostasis and vascular biology through promotion of scientific exchange via meetings, publications, and promotion of international cooperation in clinical studies, and standardization of nomenclature and practices in the Asia-Pacific region.

Editors' quotes

New Content Item

“It is with great pleasure that I join the Editorial team of Thrombosis Journal and to take on the role as co-Editor-in-Chief (EiC). This is indeed a great honor for me. For your information, I am a biochemist and have been active in the field of Thrombosis and Haemostasis with a particular interest in fibrinolysis for over 38 years. I am looking forward to making a positive contribution to Thrombosis Journal. I would very much like to thank and acknowledge the many years at the helm by my predecessor Prof Hugo Ten Cate. I will do my best to fill Hugo’s shoes. I would also like to acknowledge the long-lasting role of Yukio Ozaki as co-EiC who will be continuing in this role. I am looking forward to working with Prof Ozaki and the dedicated Associate Editors to develop and implement new ideas and approaches to improve the standing of the Journal.”

                                            Robert Medcalf, Editor-in-Chief, Thrombosis Journal

"Treatment and prophylaxis of thrombotic and bleeding disorders is of great importance to the worldwide population, and there is a great need to facilitate the research activities related to this field. The aim of Thrombosis Journal is to provide a platform on which these important studies are visible to all members of the scientific community and public."

 Yukio Ozaki, Editor-in-Chief, Thrombosis Journal

Official journal of

  • Thrombosis Journal is the official journal of the Asian-Pacific Society on Thrombosis and Hemostasis.

Annual Journal Metrics

  • 2022 Citation Impact
    3.1 - 2-year Impact Factor
    3.8 - 5-year Impact Factor
    1.011 - SNIP (Source Normalized Impact per Paper)
    0.699 - SJR (SCImago Journal Rank)

    2023 Speed
    10 days submission to first editorial decision for all manuscripts (Median)
    107 days submission to accept (Median)

    2023 Usage 
    943 Altmetric mentions